Skip to main content
Daniel Mulrooney, MD, Pediatric Hematology & Oncology, Memphis, TN

Daniel A Mulrooney MD


Assistant Professor, Pediatrics, University of Minnesota Medical School

Join to View Full Profile
  • 262 Danny Thomas PlMemphis, TN 38105

  • Phone+1 888-226-4343

Join Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Daniel Mulrooney, MD is a pediatric hematologist/oncologist in Memphis, Tennessee. He is currently licensed to practice medicine in Tennessee and Minnesota. He is an Assistant Professor at University of Minnesota Medical School.

Education & Training

  • University of Minnesota
    University of MinnesotaFellowship, Pediatric Hematology/Oncology, 2001 - 2004
  • University of Minnesota
    University of MinnesotaResidency, Internal Medicine/Pediatrics, 1997 - 2001
  • Loyola University Chicago Stritch School of Medicine
    Loyola University Chicago Stritch School of MedicineClass of 1997
  • Loyola University Chicago Stritch School of Medicine
    Loyola University Chicago Stritch School of MedicineClass of 1997

Certifications & Licensure

  • TN State Medical License
    TN State Medical License 2012 - 2027
  • MN State Medical License
    MN State Medical License 2004 - 2025
  • Pediatrics
    American Board of Pediatrics Pediatrics
  • Pediatric Hematology-Oncology
    American Board of Pediatrics Pediatric Hematology-Oncology

Publications & Presentations

PubMed

Authored Content

  • Association of Hearing Impairment with Neurocognition in Survivors of ChildhoodJuly 2020

Press Mentions

  • Adult Survivors of Childhood Cancer Are Experiencing Fewer Major Cardiac Events
    Adult Survivors of Childhood Cancer Are Experiencing Fewer Major Cardiac EventsJanuary 21st, 2020
  • Childhood Cancer Tx Less Cardiotoxic, but Heart Risks Persist
    Childhood Cancer Tx Less Cardiotoxic, but Heart Risks PersistJanuary 16th, 2020
  • Childhood Cancer Survivors Need to Be Monitored for Complications, Study Says
    Childhood Cancer Survivors Need to Be Monitored for Complications, Study SaysAugust 15th, 2016
  • Join now to see all

Grant Support

  • Research Supplements to Promote Diversity in Health-Related Research: Personalized Risk Prediction to Reduce Cardiovascular Disease in Childhood Cancer SurvivorsUNIVERSITY OF TX MD ANDERSON CAN CTR2022–2026
  • Personalized Risk Prediction to Reduce Cardiovascular Disease in Childhood Cancer SurvivorsUNIVERSITY OF TX MD ANDERSON CAN CTR2022–2026
  • Telehealth based exercise intervention to improve functional capacity in survivors of childhood cancer with significantly limited exercise toleranceST. JUDE CHILDREN'S RESEARCH HOSPITAL2020–2025